Company Overview
- Headquarters
- 377 Plantation St, Worcester MA
- Website
- mustangbio.com
- ea****@mustangbio.com
- Phone
- (781) 652-4500
- Employees
- 68
- Founded in
- 2015
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:MBI
- NAICS Code
-
NAICS Code 42421 CompaniesNAICS Code 424 CompaniesNAICS Code 32 CompaniesNAICS Code 325 CompaniesNAICS Code 621 CompaniesNAICS Code 4242 CompaniesNAICS Code 6215 CompaniesNAICS Code 62 CompaniesNAICS Code 42 CompaniesNAICS Code 62151 Companies
- SIC Code
-
SIC Code 28 CompaniesSIC Code 283 Companies
Financials & Stats
Revenue
$34B
Total Funding Amount
$75M
Who is Mustang Bio
Mustang Bio, Inc. is a clinical-stage bio-pharmaceutical company focused on cell and gene therapies. Founded in the United States, the company has a team of 72 employees with annual revenue of $50M. Mustang Bio develops CAR T and CRISPR/Cas9-enhanced CAR T therapies for various cancers and a lentiviral gene therapy for XSCID. The company's target customers include patients with hematologic cancers, solid tumors, and rare genetic diseases. Mustang Bio has partnered with leading medical institutions to advance its research and development efforts. The company is dedicated to translating cutting-edge medical breakthroughs into potential cures. Mustang Bio can be reached through their website at mustangbio.com.
Company Leadership
Mustang Bio Tech Stack
Companies Similar to Mustang Bio
Analyze industry trends and opportunities by examining competitors and companies comparable to Mustang Bio, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 34M | 18 | South San Francisco, CA | 2008 | |
| 34M | 13 | Hardwick, MA | 1994 | |
| 34M | 95 | Framingham, MA | 2014 | |
| 33M | 65 | 1980 | ||
| 32M | 10 | Amherst, NH | 2011 |